TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG.

C H Smorenburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.